Your shopping cart is empty!
PDF Preview
Clinical and Laboratory Standards Institute, 06/21/2022
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:21/06/2022
Pages:104
File Size:1 file , 6.8 MB
Note:This product is unavailable in Russia, Belarus
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology.
Molecular Methods for Bacterial Strain Typing; Proposed Guideline, MM11-P
$115.00 $230.43
Application of a Quality Management System Model for Inpatient Medication Use; Approved Guideline, QMS09A2E
$148.00 $297.22
Application of a Quality Management System Model for Medical Imaging Services; Approved Guideline, QMS08A2E
$148.00 $296.26
Newborn Screening Follow-up; Approved Guideline, ILA27A
$126.00 $253.35
